Evaluation of proliferating cell nuclear antigen as a surrogate end point biomarker in actinic keratosis and adjacent, normal-appearing, and non-sun-exposed human skin samples

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 5, 1996, Pages 343-348

  Einspahr, Janine ^a   Alberts, David S ^a,c   Aickin, Mikel ^a   Welch, Kevin ^a,b   Bozzo, Paul ^a   Levine, Norman ^a   Grogan, Thomas ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Medical Center Clinic Pensacola   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CYCLINE;

ACTINIC KERATOSIS; ANIMAL TISSUE; ARTICLE; CANCER RISK; CELL PROLIFERATION; EPIDERMIS CELL; HISTOPATHOLOGY; HUMAN; LABELING INDEX; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CANCER; SUN EXPOSURE;

AGED; AGED, 80 AND OVER; ARM; BIOLOGICAL MARKERS; BIOPSY; BUTTOCKS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CHEMOPREVENTION; COLORING AGENTS; EPIDERMIS; EVALUATION STUDIES; FEMALE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RISK FACTORS; SKIN; SKIN NEOPLASMS; SUNLIGHT; TUMOR MARKERS, BIOLOGICAL;

EID: 0029961162     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kwa, R. E., Campana, K., and Moy, R. L. Biology of cutaneous squamous cell carcinoma. J. Am. Acad. Dermatol., 26: 1-26, 1992.
2. Marks, R. An overview of skin cancers. Cancer (Phila.), 75: 607-612, 1995.
3. Kuflik, A. S., and Schwartz, R. A. Actinic keratosis and squamous cell carcinoma. Am. Fam. Physician, 49: 817-820, 1994.
4. Sober, A. J., and Burstein, J. M. Precursors to skin cancer. Cancer (Phila.), 75: 645-650, 1995.
5. Dodson, J. M., DeSpain, J., Hewett, J. E., and Clark, D. P. Malignant potential of actinic keratosis and the controversy over treatment. A patient-oriented perspective. Arch. Dermatol., 127: 1029-1031, 1991.
6. Marks, R. Solar keratosis. Br. J. Dermatol., 122 (Suppl. 35): 49-60, 1990.
7. Morse, M. A., and Stoner, G. D. Cancer chemoprevention: principles and prospects. Carcinogenesis (Lond.), 14: 1737-1746, 1993.
8. Soini, Y., Paakko, P., Lehto, V-P., Oikarinen, A., and Vahakangas, K. Aberrant accumulation of p53 associates with Ki67 and mitotic count in benign skin lesions. Br. J. Dermatol., 131: 514-520, 1994.
9. Szekeres, G., and De Giacomoni, P. Ki-67 and p53 expression in cutaneous Bowen's disease: an immunohistochemical study of fixed-embedded tissue sections. Acta Dermato-Venereol., 74: 95-97, 1994.
10. Kanitakis, J. K., Hoyo, E., Chouvet, B., Thivolet, J., Faure, M., and Claudy, A. Keratinocyte proliferation in epidermal keratinocyte disorders evaluated through PCNA/cyclin immunolabeling and AgNOR counting. Acta Dermato-Venereol., 73: 370-375, 1993.
11. Morimoto, Y., Saga, K., Bando, M., and Takahashi, M. In vitro DNA synthesis of keratinocytes in normal human skin, psoriasis, seborrheic keratosis, Bowen's disease and basal cell carcinoma. Br. J. Dermatol., 725: 9-13, 1991.
12. Pennys, N. S., Bogaert, M., Serfling, U., and Sisto, M. PCNA expression in cutaneous keratinous neoplasms and verruca vulgaris. Am. J. Pathol., 141: 139-142, 1992.
13. Saida, T., Dohi, S., Sadaki, M., Tokuda, Y., Ikegawa, S., and Takasaki, Y. Distribution patterns and frequency of proliferating cells in cutaneous keratinocytic neoplasms. J. Am. Acad. Dermatol., 26: 744-748, 1992.
14. Geary, W. A., and Cooper, P. H. Proliferating cell nuclear antigen (PCNA) in common epidermal lesions. J. Cutaneous Pathol., 19: 458-468, 1992.
15. Heenen, M., Achten, G., and Galand, P. Autoradiographic analysis of cell kinetics in normal human and basal cell cancer. Cancer Res., 33: 123-127, 1973.
16. Pearse, A. D., and Marks, R. Actinic keratoses and the epidermis on which they arise. Br. J. Dermatol., 96: 45-50, 1976.
17. Wolff, H. H., and Gnas, W. Immunocytochemical detection of in vitro incorporated 5-bromodeoxyuridine in paraffin sections of human skin. Arch. Dermatol. Res., 287: 209-212, 1989.
18. Weinstein, G. D., McCullough, J. L., and Ross, P. Cell proliferation in normal epidermis. J. Invest. Dermatol., 82: 623-628, 1984.
19. Kahn, G., Weinstein, G. D., and Frost, P. Kinetics of human epidermal cell proliferation: diurnal variation. J. Invest. Dermatol., 50: 459-462, 1968.
20. Weinstein, G. D., and Frast, P. Cell proliferation kinetics in benign and malignant skin diseases in humans. Natl. Cancer Inst. Monogr., 30: 225-246, 1969.
21. Pennys, N. S., Fulton, J. E., Weinstein, G. D., and Ford, P. Location of proliferating cells in human epidermis. Arch. Dermatol., 101: 323-327, 1970.
22. Van Erp, P. E., De Mare, S., Rijzewijk, J. J., Van de Kerkhof, P. C., and Bauer, F. W. A sequential double immunoenzymic staining procedure to obtain cell kinetic information in normal and hyperproliferative epidermis. Histochem. J., 21: 343-347, 1989.
23. Lachapelle, J. M., and Gillman, T. Tritiatied thymidine labelling of normal human epidermal cell nuclei. Br. J. Dermatol., 81: 603-616, 1969.
24. Gelfant, S., Ozawa, A., Chalker, D. K., and Smith, J. G. Circadian rhythms and differences in epidermal and in dermal cell proliferation in uninvolved and involved psoriatic skin in vitro. J. Invest. Dermatol., 78: 58-62, 1982.
25. 3H]thymidine incorporation and immunoperoxidse staining of 67 K polypeptide. Br. J. Dermatol., 108: 433-430, 1983.
26. Christophers, E., and Schaumloffel, E. Zur DNS-synthesezeit in der menschlichen epidermis. Arch. Klin. Exp. Dermatol., 228: 57-64, 1967.
27. Heene, M., Lambert, J. C., Achten, G., and Galand, P. Kinetics of cell proliferation in benign and premalignant tumors of human epidermis. J. Natl. Cancer Inst., 54: 825-827, 1975.
28. Steigleder, G. K., Schomann, H., and Lennartz, K. J. Autoradiographic in vitro examination of psoriatic skin before, during and after Dithranol treatment. Arch. Dermatol. Forsch., 246: 231-235, 1973.
29. Pullman, H., Lennartz, K. J., and Steigleder, G. K. In vitro examination of cell proliferation in normal and psoriatic epidermis, with special regard to diurnal variation. Arch. Dermatol. Forsch., 250: 177-184, 1974.
30. Pappas, A. A., Maners, A. W.. Owens, R. B., Thompson, J. R., King, J. C., and Dinehart, S. M. Deoxyribonucleic acid (DNA) ploidy and proliferative characteristics of metastatic cell carcinoma determined by flow cytometric analysis. J. Dermatol. Surg. Oncol., 18: 957-960, 1992.
31. Randall, M. B., Geisinger, K. R., Kute, T. E., Buss, D. H., and Prichard, R. W. DNA content and proliferative index in cutaneous squamous cell carcinoma and keratoacanthoma. Am. J. Clin. Pathol., 93: 259-262, 1990.
32. Prelich, G., Tan, C-K., Kostura, M., Mathews, M. B., So, A. G., Downey, K. M., and Stillman, B. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature (Lond.), 326: 517-520, 1987.
33. Bravo, R., Frank, R., Blundell, P. A., and Macdonald-Bravo, H. Cyclin/ PCNA is the auxiliary protein of DNA polymerase-delta. Nature (Lond.), 326: 515-517, 1987.
34. Cells, J. E., and Madsen, P. Increased nuclear cyclin/PCNA antigen staining of non S-phase transformed human amnion cells engaged in nucleotide excision DNA repair. FEBS Lett., 209: 277-283, 1986.